Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 11.01
(-0.27%)
CNY 11.01
(-0.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -527.44 Million CNY | -1968.65% |
| 2022 | -25.49 Million CNY | 94.89% |
| 2021 | -499.38 Million CNY | 17.82% |
| 2020 | -607.64 Million CNY | -916.96% |
| 2019 | 74.37 Million CNY | 180.33% |
| 2018 | -92.59 Million CNY | 81.05% |
| 2017 | -488.53 Million CNY | -120.21% |
| 2016 | -221.85 Million CNY | -789.12% |
| 2015 | 32.19 Million CNY | 117.44% |
| 2014 | -184.55 Million CNY | 38.51% |
| 2013 | -300.13 Million CNY | 66.91% |
| 2012 | -906.97 Million CNY | -1.32% |
| 2011 | -895.14 Million CNY | 15.04% |
| 2010 | -1.05 Billion CNY | 1.43% |
| 2009 | -1.06 Billion CNY | -2997.96% |
| 2008 | 36.88 Million CNY | -17.71% |
| 2007 | 44.82 Million CNY | 192.84% |
| 2006 | 15.3 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -90.34 Million CNY | 90.68% |
| 2024 Q2 | -969.05 Million CNY | -84.75% |
| 2024 Q1 | -524.51 Million CNY | 0.55% |
| 2023 Q4 | -527.44 Million CNY | 42.07% |
| 2023 Q1 | -445.38 Million CNY | -1646.83% |
| 2023 FY | -527.44 Million CNY | -1968.65% |
| 2023 Q3 | -910.51 Million CNY | 14.6% |
| 2023 Q2 | -1.06 Billion CNY | -139.39% |
| 2022 Q2 | -280.84 Million CNY | 39.36% |
| 2022 Q1 | -463.1 Million CNY | 7.27% |
| 2022 Q3 | -86.49 Million CNY | 69.2% |
| 2022 FY | -25.49 Million CNY | 94.89% |
| 2022 Q4 | -25.49 Million CNY | 70.52% |
| 2021 Q4 | -499.38 Million CNY | -107.22% |
| 2021 Q1 | -672.59 Million CNY | -10.69% |
| 2021 FY | -499.38 Million CNY | 17.82% |
| 2021 Q3 | -240.99 Million CNY | -326.33% |
| 2021 Q2 | -56.52 Million CNY | 91.6% |
| 2020 Q2 | -161.1 Million CNY | -465.26% |
| 2020 Q4 | -607.64 Million CNY | -62.58% |
| 2020 Q3 | -373.75 Million CNY | -132.0% |
| 2020 Q1 | 44.1 Million CNY | -40.7% |
| 2020 FY | -607.64 Million CNY | -916.96% |
| 2019 Q4 | 74.37 Million CNY | 206.15% |
| 2019 FY | 74.37 Million CNY | 180.33% |
| 2019 Q3 | -70.06 Million CNY | 30.02% |
| 2019 Q2 | -100.12 Million CNY | 53.57% |
| 2019 Q1 | -215.64 Million CNY | -132.9% |
| 2018 Q3 | -4.09 Million CNY | 98.69% |
| 2018 Q4 | -92.59 Million CNY | -2162.91% |
| 2018 FY | -92.59 Million CNY | 81.05% |
| 2018 Q1 | -240.92 Million CNY | 50.68% |
| 2018 Q2 | -312.39 Million CNY | -29.66% |
| 2017 Q1 | -216.87 Million CNY | 2.24% |
| 2017 FY | -488.53 Million CNY | -120.21% |
| 2017 Q4 | -488.53 Million CNY | -1660.32% |
| 2017 Q3 | -27.75 Million CNY | 83.06% |
| 2017 Q2 | -163.8 Million CNY | 24.47% |
| 2016 Q2 | 28.01 Million CNY | 114.16% |
| 2016 Q1 | -197.9 Million CNY | -714.73% |
| 2016 FY | -221.85 Million CNY | -789.12% |
| 2016 Q4 | -221.85 Million CNY | 67.27% |
| 2016 Q3 | -677.87 Million CNY | -2519.57% |
| 2015 Q3 | 22 Million CNY | 143.78% |
| 2015 Q2 | -50.26 Million CNY | 89.76% |
| 2015 FY | 32.19 Million CNY | 117.44% |
| 2015 Q1 | -490.96 Million CNY | -166.04% |
| 2015 Q4 | 32.19 Million CNY | 46.29% |
| 2014 Q1 | -291.22 Million CNY | 2.97% |
| 2014 Q4 | -184.55 Million CNY | -4.59% |
| 2014 Q3 | -176.45 Million CNY | 58.55% |
| 2014 FY | -184.55 Million CNY | 38.51% |
| 2014 Q2 | -425.75 Million CNY | -46.2% |
| 2013 Q2 | -414.29 Million CNY | 49.35% |
| 2013 Q3 | -255.28 Million CNY | 38.38% |
| 2013 FY | -300.13 Million CNY | 66.91% |
| 2013 Q1 | -817.93 Million CNY | 9.82% |
| 2013 Q4 | -300.13 Million CNY | -17.57% |
| 2012 Q3 | -882.11 Million CNY | -2.94% |
| 2012 Q4 | -906.97 Million CNY | -2.82% |
| 2012 FY | -906.97 Million CNY | -1.32% |
| 2012 Q1 | -928.53 Million CNY | -3.73% |
| 2012 Q2 | -856.91 Million CNY | 7.71% |
| 2011 Q2 | -908.16 Million CNY | 15.76% |
| 2011 Q4 | -895.14 Million CNY | 0.03% |
| 2011 Q3 | -895.39 Million CNY | 1.41% |
| 2011 FY | -895.14 Million CNY | 15.04% |
| 2011 Q1 | -1.07 Billion CNY | -2.32% |
| 2010 Q2 | -1.02 Billion CNY | 4.98% |
| 2010 Q3 | -1.05 Billion CNY | -3.3% |
| 2010 Q1 | -1.07 Billion CNY | -0.88% |
| 2010 Q4 | -1.05 Billion CNY | 0.44% |
| 2010 FY | -1.05 Billion CNY | 1.43% |
| 2009 Q2 | 30.94 Million CNY | 0.0% |
| 2009 Q3 | 2.41 Million CNY | -92.2% |
| 2009 Q4 | -1.06 Billion CNY | -44369.41% |
| 2009 FY | -1.06 Billion CNY | -2997.96% |
| 2008 FY | 36.88 Million CNY | -17.71% |
| 2008 Q4 | 36.88 Million CNY | 0.0% |
| 2007 FY | 44.82 Million CNY | 192.84% |
| 2006 FY | 15.3 Million CNY | 0.0% |